# SLC25A33

## Overview
SLC25A33 is a gene that encodes the protein solute carrier family 25 member 33, a mitochondrial transporter involved in the exchange of pyrimidine nucleotides between the cytosol and mitochondria. This protein is a member of the solute carrier family 25, characterized by its six transmembrane alpha-helices that facilitate the transport of molecules across the mitochondrial membrane (Palmieri2013The; Pasquadibisceglie2021Computational). The SLC25A33 protein functions as a homodimer and is primarily expressed in the liver and testis, with lower expression levels in the heart and brain (Gutiérrez-Aguilar2013Physiological). It plays a crucial role in mitochondrial DNA replication and repair by transporting pyrimidine nucleotides, which are essential for maintaining mitochondrial function and supporting cellular energy metabolism (Palmieri2013The; Curcio2020Drosophila). The gene's expression is implicated in various pathological conditions, including cancer, where its overexpression is associated with increased cell proliferation and altered metabolic activity (Gutiérrez-Aguilar2013Physiological).

## Structure
The SLC25A33 protein is a member of the solute carrier family 25, which is characterized by a conserved structure featuring six transmembrane alpha-helices. These helices form a funnel-shaped structure that facilitates the transport of molecules across the mitochondrial membrane (Palmieri2013The; Pasquadibisceglie2021Computational). The protein's structure includes three homologous domains, each containing two hydrophobic regions separated by a hydrophilic sequence, contributing to its tripartite architecture (Palmieri2013The).

The SLC25A33 protein functions as a homodimer, which is a common quaternary structure among members of the SLC25 family. This dimerization is crucial for its transport activity (Pasquadibisceglie2021Computational). The protein's transport mechanism involves conformational changes between a cytoplasmic state and a matrix state, facilitated by salt bridges formed by conserved motifs (Pasquadibisceglie2021Computational).

Post-translational modifications and splice variants can influence the function and localization of SLC25A33, although specific details on these modifications for SLC25A33 are not provided in the context. The protein is primarily expressed in the liver and testis, with lower expression levels in the heart and brain (Gutiérrez-Aguilar2013Physiological).

## Function
SLC25A33, also known as the pyrimidine nucleotide carrier PNC1, is a mitochondrial transporter involved in the exchange of pyrimidine nucleotides between the cytosol and mitochondria. It primarily facilitates the transport of uridine triphosphate (UTP), followed by thymidine triphosphate (TTP) and cytidine triphosphate (CTP), into the mitochondria, which is crucial for mitochondrial DNA (mtDNA) replication and repair (Curcio2020Drosophila; Gutiérrez-Aguilar2013Physiological). This transport process is essential for maintaining mitochondrial function, as it supports the synthesis and transcription of mtDNA, which are vital for oxidative phosphorylation and energy production in cells (Palmieri2013The).

SLC25A33 operates as an obligatory counter-exchanger, importing pyrimidine nucleotides in exchange for intramitochondrial pyrimidine nucleoside diphosphates (dNDPs) (Curcio2020Drosophila). The protein is expressed primarily in the liver and testis, with lower levels in the heart and brain, indicating its role in tissues with high metabolic demands (Gutiérrez-Aguilar2013Physiological). In healthy cells, SLC25A33's function is critical for maintaining the nucleotide balance necessary for mtDNA integrity, thereby supporting cellular energy metabolism and overall cell function (Palmieri2013The).

## Clinical Significance
The SLC25A33 gene is implicated in various pathological conditions, primarily through its role in cancer cell proliferation. Overexpression of SLC25A33 has been associated with increased cell size and proliferation in breast cancer cells, along with suppressed reactive oxygen species (ROS) production, suggesting a potential role in oncogenesis (Gutiérrez-Aguilar2013Physiological). Additionally, SLC25A33 expression is higher in cancer cell lines and primary prostate cancers compared to normal tissue, indicating its involvement in cancer progression. This expression is activated by insulin and insulin growth factor via the mTOR pathway, which is crucial for mitochondrial DNA synthesis and transcription, essential for oxidative phosphorylation (Palmieri2013The).

While the specific clinical significance of SLC25A33 gene mutations is not detailed, its altered expression levels in cancer suggest it may contribute to tumorigenesis. The gene's role in transporting pyrimidine nucleotides into mitochondria is vital for maintaining mitochondrial function, and disruptions in this process could potentially lead to metabolic disorders or mitochondrial diseases. However, further research is needed to fully elucidate the clinical implications of SLC25A33 mutations or expression alterations.


## References


[1. (Palmieri2013The) Ferdinando Palmieri. The mitochondrial transporter family slc25: identification, properties and physiopathology. Molecular Aspects of Medicine, 34(2–3):465–484, April 2013. URL: http://dx.doi.org/10.1016/j.mam.2012.05.005, doi:10.1016/j.mam.2012.05.005. This article has 612 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.mam.2012.05.005)

[2. (Curcio2020Drosophila) Rosita Curcio, Paola Lunetti, Vincenzo Zara, Alessandra Ferramosca, Federica Marra, Giuseppe Fiermonte, Anna Rita Cappello, Francesco De Leonardis, Loredana Capobianco, and Vincenza Dolce. Drosophila melanogaster mitochondrial carriers: similarities and differences with the human carriers. International Journal of Molecular Sciences, 21(17):6052, August 2020. URL: http://dx.doi.org/10.3390/ijms21176052, doi:10.3390/ijms21176052. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21176052)

[3. (Pasquadibisceglie2021Computational) Andrea Pasquadibisceglie and Fabio Polticelli. Computational studies of the mitochondrial carrier family slc25. present status and future perspectives. Bio-Algorithms and Med-Systems, 17(2):65–78, April 2021. URL: http://dx.doi.org/10.1515/bams-2021-0018, doi:10.1515/bams-2021-0018. This article has 2 citations.](https://doi.org/10.1515/bams-2021-0018)

[4. (Gutiérrez-Aguilar2013Physiological) Manuel Gutiérrez-Aguilar and Christopher P. Baines. Physiological and pathological roles of mitochondrial slc25 carriers. Biochemical Journal, 454(3):371–386, August 2013. URL: http://dx.doi.org/10.1042/bj20121753, doi:10.1042/bj20121753. This article has 98 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj20121753)